Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1987
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1987 1
1990 1
1991 3
1992 3
1993 4
1994 3
1995 8
1996 6
1997 7
1998 5
1999 4
2000 7
2001 4
2002 8
2003 8
2004 7
2005 5
2006 2
2007 3
2008 8
2009 3
2010 7
2011 1
2012 3
2013 5
2014 6
2015 2
2016 2
2017 6
2018 2
2019 3
2020 5
2021 8
2022 5
2023 4
2024 5
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

156 results

Results by year

Filters applied: . Clear all
Page 1
Neurotrophic keratopathy: current challenges and future prospects.
NaPier E, Camacho M, McDevitt TF, Sweeney AR. NaPier E, et al. Ann Med. 2022 Dec;54(1):666-673. doi: 10.1080/07853890.2022.2045035. Ann Med. 2022. PMID: 35243932 Free PMC article. Review.
Stage 2 treatment can involve therapeutic contact lenses, topical autologous or allogenic serum, tarsorrhaphy, botulinum toxin injections, and possibly anti-inflammatory medications. ...New therapies, such as matrix regenerating therapy, plasma rich in growth factors, Thym …
Stage 2 treatment can involve therapeutic contact lenses, topical autologous or allogenic serum, tarsorrhaphy, botulinum toxin inject …
Acromegaly.
Dineen R, Stewart PM, Sherlock M. Dineen R, et al. QJM. 2017 Jul 1;110(7):411-420. doi: 10.1093/qjmed/hcw004. QJM. 2017. PMID: 26873451 Review.
Acromegaly is a rare, chronic, progressive disease characterized by an excess secretion of growth hormone (GH) and increased circulating insulin-like growth factor 1 (IGF-1) concentrations. It is caused by a pituitary adenoma in the vast majorit …
Acromegaly is a rare, chronic, progressive disease characterized by an excess secretion of growth hormone (GH) and increased circulating …
Developments in the Management of Growth Hormone Deficiency: Clinical Utility of Somapacitan.
Miller BS, Blair J, Horikawa R, Linglart A, Yuen KCJ. Miller BS, et al. Drug Des Devel Ther. 2024 Feb 3;18:291-306. doi: 10.2147/DDDT.S315172. eCollection 2024. Drug Des Devel Ther. 2024. PMID: 38333899 Free PMC article. Review.
This daily treatment regimen often incurs a burden to patients and caregivers, leading to high rates of non-adherence and, consequently, decreased treatment efficacy outcomes. To address this shortcoming, long-acting growth hormones (LAGHs) have been developed with the aim …
This daily treatment regimen often incurs a burden to patients and caregivers, leading to high rates of non-adherence and, consequently, …
Effect of ketogenic diets on insulin-like growth factor (IGF)-1 in humans: A systematic review and meta-analysis.
Rajakumar G, Cagigas ML, Wang T, Pan AY, Pelaia T, Fuller SJ, Fontana L. Rajakumar G, et al. Ageing Res Rev. 2024 Dec;102:102531. doi: 10.1016/j.arr.2024.102531. Epub 2024 Oct 11. Ageing Res Rev. 2024. PMID: 39396675 Free article. Review.
Eligible studies prescribed KDs to adults of any health status, confirmed ketosis, and measured serum IGF-1. Protocols involving prescribed fasting or energy restriction were excluded. ...Pooled results from ten trials showed a significant reduction in serum IGF-1 l …
Eligible studies prescribed KDs to adults of any health status, confirmed ketosis, and measured serum IGF-1. Protocols involving pres …
Growth hormone.
Bidlingmaier M, Strasburger CJ. Bidlingmaier M, et al. Handb Exp Pharmacol. 2010;(195):187-200. doi: 10.1007/978-3-540-79088-4_8. Handb Exp Pharmacol. 2010. PMID: 20020365 Review.
It acts through binding to the hGH receptor, inducing either direct effects or initiating the production of insulin-like growth-factor I (IGF-I), the most important mediator of hGH effects. Growth hormone is primarily known to promote longitudin …
It acts through binding to the hGH receptor, inducing either direct effects or initiating the production of insulin-like gr
Insulin-Like Growth Factor (IGF) System in Liver Diseases.
Adamek A, Kasprzak A. Adamek A, et al. Int J Mol Sci. 2018 Apr 27;19(5):1308. doi: 10.3390/ijms19051308. Int J Mol Sci. 2018. PMID: 29702590 Free PMC article. Review.
Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors produced in liver. Insulin-like growth factor 1 and 2 (IGF1 and IGF2) act in response to growth hormone (GH). ...In epidemiologic and clinicopathological stu …
Hepatocyte differentiation, proliferation, and apoptosis are affected by growth factors produced in liver. Insulin-like gro
Retinopathy of prematurity.
Chen J, Smith LE. Chen J, et al. Angiogenesis. 2007;10(2):133-40. doi: 10.1007/s10456-007-9066-0. Epub 2007 Feb 27. Angiogenesis. 2007. PMID: 17332988 Review.
Suppression of VEGF by oxygen in phase I of ROP inhibits normal vessel growth, whereas elevated levels of VEGF induced by hypoxia in phase II of ROP precipitate pathological vessel proliferation. Insulin-like growth factor 1 (IGF-1) is a critica …
Suppression of VEGF by oxygen in phase I of ROP inhibits normal vessel growth, whereas elevated levels of VEGF induced by hypoxia in phase I …
Growth hormone and insulin-like growth factor-1 (IGF-1) and their influence on cognitive aging.
Sonntag WE, Ramsey M, Carter CS. Sonntag WE, et al. Ageing Res Rev. 2005 May;4(2):195-212. doi: 10.1016/j.arr.2005.02.001. Ageing Res Rev. 2005. PMID: 16024298 Review.
IGF-1 crosses the blood-brain barrier and in recent years, much attention has focused on age-related decreases in serum growth hormone and IGF-1 as potential mechanisms that may influence cognitive function in the elderly. ...
IGF-1 crosses the blood-brain barrier and in recent years, much attention has focused on age-related decreases in serum growth …
The Interrelationship between Insulin-Like Growth Factor 1, Apolipoprotein E epsilon4, Lifestyle Factors, and the Aging Body and Brain.
Galle SA, Geraedts IK, Deijen JB, Milders MV, Drent ML. Galle SA, et al. J Prev Alzheimers Dis. 2020;7(4):265-273. doi: 10.14283/jpad.2020.11. J Prev Alzheimers Dis. 2020. PMID: 32920629 Review.
Aging is associated with a decrease in body and brain function and with a decline in insulin-like growth factor 1 levels. ...We address the impact of age-related decline of insulin-like growth factor 1 l …
Aging is associated with a decrease in body and brain function and with a decline in insulin-like growth fact
[Functional hypothalamic amenorrhea].
Stárka L, Dušková M. Stárka L, et al. Vnitr Lek. 2015 Oct;61(10):882-5. Vnitr Lek. 2015. PMID: 26486482 Review. Czech.
Additionally, these patients present mild hypercortisolemia, low serum insulin levels, low insulin-like growth factor 1 (IGF-1) and low total triiodothyronine. Women health in this disorder is disturbed in several aspects including the sk …
Additionally, these patients present mild hypercortisolemia, low serum insulin levels, low insulin-like growth
156 results